FDA
-
-
-
-
-
-
-
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
-
-
-
-
-
-
-
FDA extends review period for GSK's Blenrep in multiple myeloma
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Sells Remaining Royalty Interest in Trelegy Ellipta to GSK (GSK) for $225M
-
-
-
-
-
-
-
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
-
-
-
-
-
-
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
-
-
-
-
-
-
-
Faruqi & Faruqi Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

